MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202621054402 A) filed by Kore Additive Manufacturing And Medical on April 29, 2026, for Decellularized Wharton’s Jelly Extract, Composition And Medium Comprising The Same And Method Thereof.
Inventors include Ms. Harshita Singh; Mr. Chaitanya Doshi; and Mr. Ravindra Doshi.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: “DECELLULARIZED WHARTON’S JELLY EXTRACT, COMPOSITION AND MEDIUM COMPRISING THE SAME AND METHOD THEREOF” ABSTRACT 5 The present disclosure provides a composition comprising decellularized Wharton’s jelly extract and a buffer. The composition is used as a nutritional supplement in cell culture media for the growth and proliferation of different cells. Being rich in growth factors, cytokines, extracellular matrix and nutrients, it is a suitable alternative to FBS in culture media. Additionally, since it is derived from discarded umbilical cord, it also 10 circumvents the ethical concerns associated with the use of FBS. Accordingly, the present disclosure also provides a cell culture media comprising the Wharton’s jelly extract composition. The present disclosure further provides a method for preparing Wharton’s jelly extract from umbilical cord as well as the Wharton’s jelly extract obtained therefrom.
Disclaimer: Curated by HT Syndication.
